BackgroundCheck.run
Search For

Glenn E Fritz, 4814608 Charter Walk Pl, Midlothian, VA 23114

Known as:
Glenn M Fritz
Related to:
Charles D Fritz Carl E Fritz 81

Glenn Fritz Phones & Addresses

14608 Charter Walk Pl, Midlothian, VA 23114   

North Chesterfield, VA   

Arlington, TN   

Bartlett, TN   

6 Lake Tahoe Cir, Bear, DE 19701   

New Castle, DE   

Camp Hill, PA   

Newark, DE   

Shiloh, TN   

Lancaster, PA   

11500 Creek Bottom Ct, North Chesterfield, VA 23236   

Education

Degree: High school graduate or higher
Get Report
Control this profile

Mentions for Glenn E Fritz

Glenn Fritz resumes & CV records

Resumes

Glenn Fritz Photo 30

Senior Scientist

Location:
Camp Hill, PA
Industry:
Pharmaceuticals
Work:
Pfizer
Senior Scientist
Education:
University of the Sciences In Philadelphia 2001 - 2005
Masters Cedar Cliff High School
University of Delaware
Glenn Fritz Photo 31

Principal Scientist

Location:
Richmond, VA
Industry:
Pharmaceuticals
Work:
Gsk Consumer Healthcare India
Principal Scientist
Skills:
Drug Delivery, Pharmaceutical Industry, Technology Transfer, Chemistry, Gmp, Formulation, Pharmacokinetics, Quality By Design, Hplc, Sop, Glp, Validation, Fda, Chromatography, Analytical Chemistry
Glenn Fritz Photo 32

Glenn Fritz

Glenn Fritz Photo 33

Glenn Fritz

Publications & IP owners

Us Patents

Coatings For Applying Substances Onto Substrate Carrier

US Patent:
2008029, Dec 4, 2008
Filed:
May 30, 2008
Appl. No.:
12/130225
Inventors:
Glenn E. Fritz - Arlington TN, US
Joseph P. Reo - Lakeland TN, US
Mohammed A. Kabir - Lakeland TN, US
International Classification:
A61K 9/48
A61K 31/137
A61K 9/20
A61K 47/10
US Classification:
424451, 514653, 514772, 424464
Abstract:
Compositions of matter containing an active agent, and methods of manufacturing thereof, wherein the method comprises the step of coating a substrate with a coating composition comprising the active agent formulated for immediate release, wherein the coating composition does not contain an appreciable amount of cellulosic materials and preferably comprises polyvinyl alcohol or a polyvinyl alcohol derived copolymer.

Phenylephrine Pharmaceutical Formulations And Compositions For Colonic Absorption

US Patent:
2008002, Jan 24, 2008
Filed:
Jun 1, 2007
Appl. No.:
11/756881
Inventors:
David Monteith - Pittstown NJ, US
John O'Mullane - Mountain Lakes NJ, US
Joseph Reo - Lakeland TN, US
Robert Nowak - New Providence NJ, US
Jiansheng Wan - Springfield NJ, US
Mohammed Kabir - Lakeland TN, US
Malaz Abutarif - North Brunswick NJ, US
Glenn Fritz - Arlington TN, US
International Classification:
A61K 31/137
A61K 31/4545
A61K 9/14
A61P 11/02
A61P 31/16
A61P 37/00
US Classification:
424497000, 424490000, 514290000, 514653000
Abstract:
The invention discloses a pharmaceutical composition comprising phenylephrine or a pharmaceutically acceptable salt thereof and an erodible layer which is for oral administration wherein the composition delivers phenylephrine or a pharmaceutically acceptable salt thereof via absorption in the colon. The pharmaceutical composition comprises a core comprising phenylephrine or a pharmaceutically acceptable salt thereof and an erodible layer which is in a time-dependent, pH-dependent, or colon-specific enzyme-dependent erodible layer that degrades to expose the core to release phenylephrine in the colon. In one preferred embodiment, the erodible layer encases the core. The composition optionally further comprises phenylephrine in the erodible layer or other additional layer(s). The pharmaceutical composition can further comprise one or more additional therapeutically active agents selected from one or more of the group consisting of antihistamines, analgesics, anti-pyretics, and non-steroidal anti-inflammatory agents. The invention also discloses methods of administering phenylephrine via the colon, thereby increasing the bioavailable amount of therapeutically active unconjugated phenylephrine relative to the total phenylephrine in the plasma.

Phenylephrine Pharmaceutical Formulations And Compositions For Colonic Abosorption

US Patent:
2015029, Oct 15, 2015
Filed:
Dec 16, 2014
Appl. No.:
14/571890
Inventors:
- Memphis TN, US
John O'Mullane - Mountain Lakes NJ, US
Robert T. Nowak - New Providence NJ, US
Jiansheng Wan - Springfield NJ, US
Mohammed A. Kabir - Lakeland TN, US
Joseph P. Reo - Lakeland TN, US
Malaz A. Abutarif - North Brunswick NJ, US
Glenn E. Fritz - Arlington TN, US
Assignee:
MSD Consumer Care, Inc. - Memphis TN
International Classification:
A61K 31/137
A61K 47/12
A61K 31/4545
A61K 47/38
A61K 9/50
A61K 9/16
Abstract:
The invention discloses a pharmaceutical composition comprising phenylephrine or a pharmaceutically acceptable salt thereof and an erodible layer which is for oral administration wherein the composition delivers phenylephrine or a pharmaceutically acceptable salt thereof via absorption in the colon. The pharmaceutical composition comprises a core comprising phenylephrine or a pharmaceutically acceptable salt thereof and an erodible layer which is in a time-dependent, pH-dependent, or colon-specific enzyme-dependent erodible layer that degrades to expose the core to release phenylephrine in the colon. In one preferred embodiment, the erodible layer encases the core. The composition optionally further comprises phenylephrine in the erodible layer or other additional layer(s). The pharmaceutical composition can further comprise one or more additional therapeutically active agents selected from one or more of the group consisting of antihistamines, analgesics, anti-pyretics, and non-steroidal anti-inflammatory agents. The invention also discloses methods of administering phenylephrine via the colon, thereby increasing the bioavailable amount of therapeutically active unconjugated phenylephrine relative to the total phenylephrine in the plasma.

Possible Relatives

Cynthia Fritz  David Fritz  Dawn N Fritz  Dean J Fritz  Deanna J Fritz  Dale J Fritz  Deborah L Fritz  Glenn Johnson  Glenn M Stanchfield  Glenn A Stanford 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.